两岸交流专题会场

2021-12-11

13:00-13:05 致辞

13:05-13:30 CML预后因素汇总-江倩

13:30-13:55 MPN研究进展-肖志坚

13:55-14:20 Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with acute myeloid leukemia-蔡承宏

14:20-14:45 外周T细胞淋巴瘤治疗: 困境和进展-周剑峰

14:45-15:10 EBV阳性淋巴瘤诊治进展-王昭

15:10-15:35 The role of TMPRSS6 variants in iron metabolism-裴松南

15:35-15:50 Is there a “gold” standard treatment for patients with isolated myeloid sarcoma? Case discussion and future perspectives- 柯博伸

15:50-16:05 以利妥昔单抗、沙利度胺及糖皮质激素治疗一例TAFRO综合征- 程平

16:05-16:30 Molecular heterogeneity unravelled by single-cell transcriptomics in patients with essential thrombocythaemia-陈志丞

16:30-16:55 新型CART细胞治疗难治复发AML-唐晓文

16:55-17:20 高危多发性骨髓瘤的治疗-王峰蓉